Literature DB >> 16672429

Plasma and liver hepatitis C virus variability in patients coinfected with human immunodeficiency virus.

Anne-Christine Jouvencel1, Didier Neau, Muriel Faure, Martine Neau, Christophe Martinaud, Elisabeth Legrand, Pascale Trimoulet, Isabelle Garrigue, Brigitte Le Bail, Paulette Bioulac-Sage, Michel Dupon, Jean-Marie Ragnaud, Herve Fleury, Marie-Edith Lafon.   

Abstract

Liver and plasma hepatitis C virus (HCV) variability was compared by E2 cloning and sequencing in three patients coinfected with HCV and human immunodeficiency virus (HIV) before and after interferon treatment and in three patients solely infected with HCV. The plasma and liver samples contained unique sequences. In the patients coinfected with HIV, accumulated random mutations produced mostly nonsynonymous substitutions in contrast to the reduced HCV genetic variability seen after treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16672429      PMCID: PMC1479191          DOI: 10.1128/JCM.44.5.1877-1880.2006

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

1.  Interferon-alpha therapy exerts selective pressure on hepatitis C virus quasispecies equilibrium.

Authors:  M Mizokami; T Ohno; K Ohba; G L Davis; K Suzuki; E Orito; J Y Lau
Journal:  Antivir Ther       Date:  1999

2.  Genetic heterogeneity of hypervariable region 1 of the hepatitis C virus (HCV) genome and sensitivity of HCV to alpha interferon therapy.

Authors:  K Sandres; M Dubois; C Pasquier; J L Payen; L Alric; M Duffaut; J P Vinel; J P Pascal; J Puel; J Izopet
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Quasispecies of hepatitis C virus in serum and in three different parts of the liver of patients with chronic hepatitis.

Authors:  A Sakai; S Kaneko; M Honda; E Matsushita; K Kobayashi
Journal:  Hepatology       Date:  1999-08       Impact factor: 17.425

4.  Intrahepatic HCV RNA loads in 37 HIV-HCV co-infected patients with controlled HIV infection.

Authors:  P Trimoulet; D Neau; B Le Bail; A Rullier; M Winnock; T Galperine; E Legrand; E Schvoerer; M Dupon; J M Ragnaud; P Bioulac-Sage; G Chêne; H Fleury; M E Lafon
Journal:  J Med Virol       Date:  2002-06       Impact factor: 2.327

5.  Influence of CD4 cell counts on the genetic heterogeneity of hepatitis C virus in patients coinfected with human immunodeficiency virus.

Authors:  Anne Marie Roque-Afonso; Mathieu Robain; Danielle Simoneau; Patricia Rodriguez-Mathieu; Michèle Gigou; Laurence Meyer; Elisabeth Dussaix
Journal:  J Infect Dis       Date:  2002-02-28       Impact factor: 5.226

6.  The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies.

Authors:  P Farci; A Shimoda; A Coiana; G Diaz; G Peddis; J C Melpolder; A Strazzera; D Y Chien; S J Munoz; A Balestrieri; R H Purcell; H J Alter
Journal:  Science       Date:  2000-04-14       Impact factor: 47.728

7.  Hepatitis C virus genetic variability in 52 human immunodeficiency virus-coinfected patients.

Authors:  Didier Neau; Anne-Christine Jouvencel; Elisabeth Legrand; Pascale Trimoulet; Tatiana Galperine; Isabelle Chitty; Michel Ventura; Brigitte Le Bail; Philippe Morlat; Jean-Yves Lacut; Jean-Marie Ragnaud; Michel Dupon; Hervé Fleury; Marie-Edith Lafon
Journal:  J Med Virol       Date:  2003-09       Impact factor: 2.327

8.  Hepatitis C virus quasispecies and response to interferon therapy in patients with chronic hepatitis C: a prospective study.

Authors:  K Hino; Y Yamaguchi; D Fujiwara; Y Katoh; M Korenaga; M Okazaki; M Okuda; K Okita
Journal:  J Viral Hepat       Date:  2000-01       Impact factor: 3.728

9.  Evolutionary study of HVR1 of E2 in chronic hepatitis C virus infection.

Authors:  Victoria Alfonso; Diego Martín Flichman; Silvia Sookoian; Viviana Andrea Mbayed; Rodolfo Héctor Campos
Journal:  J Gen Virol       Date:  2004-01       Impact factor: 3.891

10.  Impact of highly active antiretroviral therapy and immunologic status on hepatitis C virus quasispecies diversity in human immunodeficiency virus/hepatitis C virus-coinfected patients.

Authors:  Jennifer M Babik; Mark Holodniy
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

View more
  2 in total

Review 1.  Hepatitis C virus molecular evolution: transmission, disease progression and antiviral therapy.

Authors:  Maria Victoria Preciado; Pamela Valva; Alejandro Escobar-Gutierrez; Paula Rahal; Karina Ruiz-Tovar; Lilian Yamasaki; Carlos Vazquez-Chacon; Armando Martinez-Guarneros; Juan Carlos Carpio-Pedroza; Salvador Fonseca-Coronado; Mayra Cruz-Rivera
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

2.  Exceptional Heterogeneity in Viral Evolutionary Dynamics Characterises Chronic Hepatitis C Virus Infection.

Authors:  Jayna Raghwani; Rebecca Rose; Isabelle Sheridan; Philippe Lemey; Marc A Suchard; Teresa Santantonio; Patrizia Farci; Paul Klenerman; Oliver G Pybus
Journal:  PLoS Pathog       Date:  2016-09-15       Impact factor: 6.823

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.